AP
RMD icon

Aspect Partners’s ResMed RMD Stock Holding History

Aspect Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$780 Buy
4
+1
+33% +$207 ﹤0.01% 604
2026
Q1 		$673 Hold
3
– – ﹤0.01% 637
2025
Q4 		$723 Buy
+3
New +$767 ﹤0.01% 655

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aspect Partners's RMD Position: Q2 2026 in Review

Aspect Partners increased its ResMed (RMD) stake by 33% in Q2 2026, buying an estimated $207 and bringing the position to 4 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Aspect Partners first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Aspect Partners held 4 shares of ResMed worth $780 as of Q2 2026.
  • Aspect Partners bought 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #604 holding.
  • Aspect Partners first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.